Orange Book product · Generic (ANDA)
IOBENGUANE I-123
IOBENGUANE SULFATE I-123
Generic (ANDA)ANDA 213637DISCN BWXT MEDCL
At a glance
Dec 09, 2024
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 09, 2024
1 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
IOBENGUANE SULFATE I-123
Strength
10mCi/5ML (2mCi/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
Not listed
Application
ANDA 213637
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of IOBENGUANE SULFATE I-123
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
